mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.01 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
0.02 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.02 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.02 |